We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+16.03%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$3.11B
AUM Growth
+$364M
Cap. Flow
+$33.6M
Cap. Flow %
1.08%
Top 10 Hldgs %
20.36%
Holding
317
New
24
Increased
113
Reduced
139
Closed
27

Sector Composition

Rank Sector Weight
1 Healthcare 22.48%
2 Industrials 19.28%
3 Technology 19.21%
4 Communication Services 10.31%
5 Consumer Discretionary 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EFOR
126
Everforth Inc
EFOR
$1.32B
$5.54M 0.18%
87,207
-172,701
-66% -$10.8M
CLVS
127
DELISTED
Clovis Oncology, Inc.
CLVS
$5.51M 0.18%
222,165
+11,743
+6% +$294K
GRUB
128
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$5.39M 0.17%
38,789
+4,697
+14% +$728K
PII icon
129
Polaris
PII
$4.07B
$5.37M 0.17%
63,551
+8,021
+14% +$681K
TSCO icon
130
Tractor Supply
TSCO
$18B
$5.12M 0.17%
262,050
+1,400
+0.5% +$25.5K
PGTI
131
DELISTED
PGT, Inc.
PGTI
$5.06M 0.16%
365,537
+309,919
+557% +$4.9M
CARB
132
DELISTED
Carbonite Inc
CARB
$4.69M 0.15%
189,216
+50,075
+36% +$1.29M
ACRS icon
133
Aclaris Therapeutics
ACRS
$869M
$4.19M 0.13%
699,307
+158,056
+29% +$1.05M
QNST icon
134
QuinStreet
QNST
$1.21B
$4.04M 0.13%
302,124
+147,899
+96% +$2.29M
UTMD icon
135
Utah Medical Products
UTMD
$225M
$3.97M 0.13%
44,989
+21,407
+91% +$1.88M
EW icon
136
Edwards Lifesciences
EW
$51.7B
$3.92M 0.13%
61,464
-1,278
-2% -$72.9K
NGVC icon
137
Vitamin Cottage Natural Grocers
NGVC
$654M
$3.61M 0.12%
302,337
+95,458
+46% +$1.35M
CSCO icon
138
Cisco
CSCO
$479B
$3.17M 0.1%
58,789
-503
-0.8% -$24.4K
ZION icon
139
Zions Bancorporation
ZION
$10.3B
$3.06M 0.1%
67,402
-1,269
-2% -$60.5K
VMC icon
140
Vulcan Materials
VMC
$36.9B
$3M 0.1%
25,328
-467
-2% -$50.5K
UMPQ
141
DELISTED
Umpqua Holdings Corp
UMPQ
$2.97M 0.1%
180,142
-3,553
-2% -$62.6K
CSL icon
142
Carlisle Companies
CSL
$15.4B
$2.93M 0.09%
23,873
-543
-2% -$62.7K
FMC icon
143
FMC
FMC
$1.33B
$2.91M 0.09%
37,917
+4,495
+13% +$330K
ZBH icon
144
Zimmer Biomet
ZBH
$18.4B
$2.9M 0.09%
23,353
-712
-3% -$80.9K
KEX icon
145
Kirby Corp
KEX
$6.93B
$2.88M 0.09%
38,311
-985
-3% -$71.8K
FLIR
146
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$2.86M 0.09%
60,056
+14,333
+31% +$693K
BOOM icon
147
DMC Global
BOOM
$157M
$2.85M 0.09%
57,470
-3,895
-6% -$158K
NEO icon
148
NeoGenomics
NEO
$2.13B
$2.85M 0.09%
139,117
-5,358
-4% -$93.1K
XYL icon
149
Xylem
XYL
$28.1B
$2.83M 0.09%
35,858
-3,565
-9% -$260K
CSW
150
CSW Industrials
CSW
$5.71B
$2.82M 0.09%
49,236
+33,149
+206% +$1.79M

Similar funds

Rice Hall James & Associates's Q1 2019 Portfolio in Review

As of Q1 2019, Rice Hall James & Associates held 317 positions worth $3.11B, up 13% from $2.74B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Rice Hall James & Associates's Q1 2019 filing shows 24 new, 113 increased, 139 reduced and 27 closed positions. Its largest new stake was Vonage Holdings Corporation: 2,004,892 shares worth $20.1M. The largest sale was Integrated Device Technology I, an estimated $59.8M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Industrials and Technology.

  • Rice Hall James & Associates's largest Q1 2019 buy was Vonage Holdings Corporation: 2,004,892 shares worth $20.1M.
  • Rice Hall James & Associates added most to Euronet Worldwide in Q1 2019, an estimated $26M increase.
  • Rice Hall James & Associates's biggest Q1 2019 reduction was iShares Russell 2000 Growth ETF, cutting an estimated $17.4M.
  • Rice Hall James & Associates fully exited Integrated Device Technology I in Q1 2019, selling an estimated $59.8M.
  • Rice Hall James & Associates's ten largest holdings make up 20% of its $3.11B portfolio in Q1 2019.
  • Rice Hall James & Associates opened 24 new positions and closed 27 in Q1 2019.
  • Rice Hall James & Associates's portfolio value rose 13% quarter-over-quarter to $3.11B.

Based on Rice Hall James & Associates's 13F filing for Q1 2019, filed 1 May 2019.